About Polifarma
Polifarma is a company based in Rome (Italy) founded in 1919. It operates as a Direct-to-Consumer (D2C) and Professional Services. Polifarma has completed 1 acquisition, including HENNIG ARZNEIMITTEL. Polifarma offers products and services including Central Nervous System Treatments, Gastroenterology Products, Ophthalmology Solutions, Cardiovascular Medications, and Infectious Disease Treatments. Polifarma operates in a competitive market with competitors including AmerisourceBergen, Admenta Italia, LaNova Farmaceutici, Velit Biopharma and FL Group, among others.
- Headquarter Rome, Italy
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website polifarma.com
- Social LinkedIn Facebook
- Legal Name Polifarma Spa
- Investments & Acquisitions
Products & Services of Polifarma
Polifarma offers a comprehensive portfolio of products and services, including Central Nervous System Treatments, Gastroenterology Products, Ophthalmology Solutions, Cardiovascular Medications, and Infectious Disease Treatments.
Treatments for common central nervous system diseases are provided.
Various products for gastrointestinal treatment are offered by Polifarma.
Ophthalmic treatments are developed through strategic market agreements.
Cardiovascular drugs are established for significant market presence.
Antibiotics and supplements for immune support are provided.
Investments & Acquisitions by Polifarma
Polifarma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include HENNIG ARZNEIMITTEL.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Generic drugs are manufactured and supplied by Hennig Arzneimittel. | hennig-am.de | – | 1898 | Feb 2025 | •••• |
Complete acquisition details for Polifarma
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Polifarma
2 dated milestones of Polifarma across 106 years, from founding to its latest funding, stage changes and deals.
- Founded Polifarma is founded.
- Acquisition Acquires HENNIG ARZNEIMITTEL.
Competitors of Polifarma
Polifarma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, Admenta Italia, LaNova Farmaceutici, Velit Biopharma and FL Group, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| amerisourcebergen.com | 1985 | Chesterbrook, United States | – | 46,000 | Pharmaceutical distribution and supply chain services are provided globally. | |
| admentaitalia.it | 2003 | Milan, Italy | – | – | Provides wholesale pharmaceutical sales, retail pharmacies, and industry services in Italy. | |
| lanovafarmaceutici.com | 2010 | Roma, Italy | – | – | Company specializes in sales, promotion, and distribution of drugs, medical devices, supplements, and cosmetics | |
| velitnb.com | 2018 | Milan, Italy | – | – | Pharmaceutical company that specializes in the development, distributing, and manufacturing of bio and nano pharmaceuticals, medical devices, and food supplements | |
| fl-group.it | 2013 | Vado Ligure, Italy | – | – | Cannabis raw materials services are provided by FL Group. | |
| errekappa.it | 1960 | Milano, Italy | – | – | Italian company specializing in cardiology pharmaceuticals and clinical nutrition products. | |
| grammafarmaceutici.com | 1982 | Fiano Romano, Italy | – | – | A distributor of a wide range of pharmaceutical drugs. | |
| phoenixpharmaitalia.it | 2023 | Milano, Italy | – | – | Provides wholesale distribution, retail pharmacies, and services for the pharmaceutical industry in Italy. | |
| biofinpharma.com | 1989 | Milano, Italy | – | – | Develops and markets pharmaceutical products, including genetics and OTC items in Middle East regions. |
Detailed competitors of Polifarma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Polifarma
Complete news archive for Polifarma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Polifarma
10 companies that operate in the same segment as Polifarma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Polifarma
Polifarma was founded in 1919.
Polifarma is headquartered in Rome, Italy. It is registered at Rome, Lazio, Italy.
Polifarma S.p.A. is focused on the development and distribution of pharmaceutical products across various therapeutic areas. Key sectors include central nervous system, gastroenterology, ophthalmology, cardiovascular, and infectious diseases. Solutions are tailored for healthcare professionals and aim to improve quality of life through innovative medicines and research. The company is recognized for its continuous growth and commitment to future-oriented medical advancements.
Polifarma's top competitors include AmerisourceBergen, FL Group and Velit Biopharma.
Polifarma offers Central Nervous System Treatments, Gastroenterology Products, Ophthalmology Solutions, Cardiovascular Medications, and Infectious Disease Treatments.
Polifarma has made 1 acquisition, including HENNIG ARZNEIMITTEL.
Polifarma operates through Polifarma Spa.